A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

Stopped early · Phase 2

Conditions studied: HIV-1

In brief

The purpose of the protocol is to assess long-term safety and tolerability of subjects who discontinue for any reason from UK-453,061 qualifying studies.

Key facts

Study ID

NCT00824369

Run by

Pfizer

People needed

52

Starts

2009-07-01

Expected to finish

2013-07-01

Last updated by the study team

2014-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous participation in a qualifying study.
• Male or female at least 18 years of age available for a follow-up period of at least 96 weeks.

You may not qualify if…

• Concurrent treatment in another clinical trial.
• Unwilling or unable to be followed for 12 months

Where it is running

• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Curitiba, Paraná, Brazil
• Pfizer Investigational Site — Nova Iguaçu, Rio de Janeiro, Brazil
• Pfizer Investigational Site — Campinas, São Paulo, Brazil
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — Milan, Italy
• Pfizer Investigational Site — Kota Bharu, Kelantan, Malaysia
• Pfizer Investigational Site — Warsaw, Poland
• Pfizer Investigational Site — Lisbon, Portugal
• Pfizer Investigational Site — Porto, Portugal
• Pfizer Investigational Site — Ponce, Puerto Rico
• Pfizer Investigational Site — Santurce, Puerto Rico
• Pfizer Investigational Site — Dundee, KwaZulu-Natal, South Africa
• Pfizer Investigational Site — Cape Town, Western Cape, South Africa
• Pfizer Investigational Site — Lugano, Switzerland
• Pfizer Investigational Site — Sankt Gallen, Switzerland
• Pfizer Investigational Site — Donetsk, Ukraine
• Pfizer Investigational Site — Edinburgh, United Kingdom
• Pfizer Investigational Site — Edinburgh, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.